CHA AI Healthkare

차AI헬스케어 · 025620

Materials Chemicals · KOSPI

Small-cap

Market cap US$81.1M (₩112B)

Overview

CHA AI Healthkare develops and makes skincare, makeup, and personal-care products for everyday consumers.

It is listed on KOSPI, South Korea's main stock exchange, and pursues international distribution through digital channels. The company's product development is grounded in dermatological science and high-performance ingredients, with an active focus on expanding lines for sensitive skin and incorporating customisable formulation technology.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$5.3M

▼ −53.4% YoY

Operating profit · FY2025

−US$5.4M

Loss widened

Net income · FY2025

US$990.5K

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$12.3M(₩17B)	US$11.4M(₩15.7B)	US$5.3M(₩7.3B)
Operating profit	−US$7.4M(−₩10.2B)	−US$3.9M(−₩5.4B)	−US$5.4M(−₩7.5B)
Net income	−US$4.9M(−₩6.8B)	−US$6.9M(−₩9.5B)	US$990.5K(₩1.4B)

Revenue

FY2023US$12.3M
FY2024US$11.4M
FY2025US$5.3M

Operating profit

FY2023−US$7.4M
FY2024−US$3.9M
FY2025−US$5.4M

Net income

FY2023−US$4.9M
FY2024−US$6.9M
FY2025US$990.5K

Key ratios (FY2025)

ROE

1.8%

Debt/Eq

46.2%

Op. margin

-102.1%

Net margin

18.7%

Rev. YoY

▼ −53.4%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?